mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.00062 |
1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.00064 |
1 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.00075 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00061 |
1 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00067 |
1 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.00076 |
1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.00056 |
1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00043 |
1 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.00033 |
1 |